Does Dehydroepiandrosterone supplementation improve reproductive outcomes in patients with normal ovarian reserve undergoing in vitro fertilization? : A systematic review and meta-analysis
Perelló, Maria Antonia (Clínica Fertty)
Moreno, José Antonio (Clínica de la Mujer Medicina Reproductiva (Viña del Mar, Xile))
Crespo, Miriam (Hospital de Mendaro (Gipuzkoa))
Espinós, Juan José (Universitat Autònoma de Barcelona. Departament de Pediatria, Obstetrícia i Ginecologia i de Medicina Preventiva i Salut Pública)
Checa, Miguel Angel (Universitat Pompeu Fabra)

Data:	2022
Resum:	Objective: The aim of this systematic review and meta-analysis is to study the efficacy of Dehydroepiandrosterone in patients with normal ovarian reserve undergoing in vitro fertilization treatment. Design: Systematic review and meta-analysis. Setting: Centers for reproductive care. Patients: Patients with normal ovarian reserve (NOR) undergoing in vitro fertilization treatment and previously supplemented or not with DHEA. Intervention: A comprehensive electronic literature search was conducted in Pubmed, the Cochrane Library and Web of Science up to March 2021. Randomized controlled trials studying the effect of DHEA supplementation on reproductive outcomes in patients with normal ovarian reserve were included. Main outcome measures: The outcomes of interest were miscarriage rate, clinical pregnancy rate and live birth rate per embryo transfer. Results: DHEA supplementation, compared with placebo or no treatment, was associated with a significant decrease in miscarriage rate (OR = 0. 30, 95% CI: 0. 10-0. 93; p = 0. 04) in DHEA group. In contrast, there were no statistically significant differences in live birth rate (OR = 1. 52, 95% CI: 0. 8-2. 89; p = 0. 2) or clinical pregnancy rate (OR = 1. 19, 95% CI: 0. 73-1. 95; p = 0. 47) per embryo transfer. There were also no statistically significant differences in the number of oocytes (MD = 0. 66 95% CI: - 0. 04-1. 36; p = 0. 07) or metaphase II oocytes retrieved (MD = 0. 32 95% CI: -0. 12-0. 76; p = 0. 16) in one IVF cycle between the two groups. Conclusions: Our study suggested that DHEA supplementation could improve the miscarriage rate in NOR patients who underwent IVF treatment. However, no increase in clinical pregnancy rate, live birth rate or number of oocytes retrieved per IVF cycle could be demonstrated.
Drets:	Aquest material està protegit per drets d'autor i/o drets afins. Podeu utilitzar aquest material en funció del que permet la legislació de drets d'autor i drets afins d'aplicació al vostre cas. Per a d'altres usos heu d'obtenir permís del(s) titular(s) de drets.
Llengua:	Anglès
Document:	Article ; recerca ; Versió acceptada per publicar
Matèria:	Dehydroepiandrosterone supplementation ; Pregnancy outcome ; Normal ovarian reserve
Publicat a:	Medicina reproductiva y embriología clínica, Vol. 9 Núm. 3 (2022) , p. 100120, ISSN 2340-9320

DOI: 10.1016/j.medre.2022.100120

Postprint 17 p, 647.5 KB

El registre apareix a les col·leccions:
Articles > Articles de recerca
Articles > Articles publicats